INTERDISCIPLINARY APPROACH TO THE SYNDROME OF ACUTE HEPCENARY FAILURE


如何引用文章

全文:

详细

In the review the data concerning an etiopathogenesis and clinical manifestations of the acute liver failure (ALF) and also potential options of alternative treatment are considered: Orthotopic transplantation of liver and modern approaches to patient maintenance. The ALF syndrome, despite the progress in the intensive therapy modes, represents a clinical syndrome with the high mortality rate. In healthy adults, especially in cases aged of up to 30 years ALF syndrome represents a significant intredisciplinary problem in terms of diagnostics and maintenance tactics. The clinical picture is most often presented by the hepatic dysfunction, development of a coagulopathy and change of biochemical indices of the liver function, with the development of encephalopathy and polyorganic insufficiency. The lethality rate in this syndrome reaches 50%. The high mortality rate, severity of the course, etiologic heterogeneity causes the need of the development of standards for the supporting therapy. Thanks to achievements in the field of the intensive therapy and the use of the emergency transplantation of a liver allograft survival indices have considerably been improved in recent years.

作者简介

Vera Tetova

Russian Medical Academy on Continual Professional Education

Email: tetovera@yandex.ru
MD, PhD, associate professor of the Department of infectious diseases of the Russian Medical Academy of Postgraduate Education Studies, 2/1, Barrikadnaya Str., Moscow, 125993, Russian Federation. 2/1, Barrikadnaya Str., Moscow, 125993, Russian Federation

O. Burgasova

Russian Medical Academy on Continual Professional Education

2/1, Barrikadnaya Str., Moscow, 125993, Russian Federation

V. Volkova

Russian Medical Academy on Continual Professional Education

2/1, Barrikadnaya Str., Moscow, 125993, Russian Federation

N. Belyaeva

Russian Medical Academy on Continual Professional Education

2/1, Barrikadnaya Str., Moscow, 125993, Russian Federation

参考

  1. Bernal W., Wendon J. et al. Systematic review: Аcute liver failure. N. Engl. J. Med. 2013; 369: 2525-34.
  2. Bower W.A., Johns M., Margolis H.S., Williams I.T., Bell B.P. Population-based surveillance for acute liver failure. Am. J. Gastroenterol. 2007; 102: 2459-63.
  3. Kumar R., Shalimar, Bhatia V. et al. Antituberculosis therapy-induced acute liver failure: magnitude, profile, prognosis, and predictors of outcome. Hepatology. 2010; 51: 1665-74.
  4. Lee W.M., Stravitz R.T., Larson A.M. Introduction to the revised American Association for the Study of Liver Diseases Position Paper on acute liver failure. 2011.
  5. Bernal W., Hyyrylainen A., Gera A. et al. Lessons from look-back in acute liver failure? A single centre experience of 3300 patients. J. Hepatol. 2013; 59: 74-80.
  6. Trey C., Davidson C.S. The management of fulminant hepatic failure. Prog. Liver Dis. 1970; 3: 282-98.
  7. Wlodzimirow K.A., Eslami S., Abu-Hanna A., Nieuwoudt M., Chamuleau R.A. Systematic review: acute liver failure - one disease, more than 40 definitions. Aliment. Pharmacol. Ther. 2012; 35: 1245-56.
  8. O’Grady J.G., Schalm S.W., Williams R. Acute liver failure: redefining the syndromes. Lancet. 1993; 342: 273-5 Erratum. Lancet. 1993; 342: 1000.
  9. Bernuau J., Rueff B., Benhamou J.P. Fulminant and subfulminant liver failure: definitions and causes. Semin Liver Dis. 1986; 6: 97-106.
  10. Mochida S., Nakayama N., Matsui A., Nagoshi S., Fujiwara K. Re-evaluation of the Guideline published by the Acute Liver Failure Study Group of Japan in 1996 to determine the indications of liver transplantation in patients with fulminant hepatitis. Hepatol. Res. 2008; 38: 970-9.
  11. Hoofnagle J.H., Nelson K.E., Purcell R.H. Hepatitis E. N. Engl. J. Med. 2012; 367: 1237-44.
  12. Wasley A., Fiore A., Bell B.P. Hepatitis A in the era of vaccination. Epidemiol. Rev. 2006; 28: 101-11.
  13. Karetkina G.N. Viral hepatitis A in the past, present and future. (in Russian)
  14. Krasnitskiy E. Pathology and Hematology. Hepatocellular insufficiency [electronic resource]. http://pathanatom.ru/patologicheskaya-anatomiya/makroskopicheskaya-diagnostika/pechenochno-kletochnaya-nedostatochnost (date 6.11.15g treatment.). (in Russian)
  15. Khuroo M.S., Kamili S. Aetiology and prognostic factors in acute liver failure in India. J. Viral Hepat. 2003; 10: 224-31.
  16. Torres H.A., Davila M. Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer. Nat. Rev. Clin. Oncol. 2012; 9: 156-66.
  17. Ichai P., Samuel D. Etiology and prognosis of fulminant hepatitis in adults. Liver Transpl. 2008; 14 (Suppl. 2): S67-79.
  18. Larson A.M., Polson J., Fontana R.J., Davern T.J., Lalani E., Hynan L.S. et al. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology. 2005; 42 (6): 1364-72.
  19. Craig D.G.N., Bates C.M., Davidson J.S., Martin K.G., Hayes P.C., Simpson K.J. Staggered overdose pattern and delay to hospital presentation are associated with adverse outcomes following paracetamol-induced hepatotoxicity. Br. J. Clin. Pharmacol. 2012; 73: 285-94.
  20. Myers R.P., Shaheen A.A.M., Li B., Dean S., Quan H. Impact of liver disease, alcohol abuse, and unintentional ingestions on the outcomes of acetaminophen overdose. Clin. Gastroenterol. Hepatol. 2008; 6: 918-25.
  21. Rezende G. Roque-Afonso A.M., Samuel D. et al. Viral and clinical factors associated with the fulminant course of hepatitis A infection. Hepatology. 2003; 38: 613-8.
  22. Chalasani N., Fontana R.J., Bonkovsky H.L. et al. Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology. 2008; 135: 1924-34.
  23. Paterson J.M., Mamdani M.M., Manno M, Juurlink DN. Fluoroquinolone therapy and idiosyncratic acute liver injury: a population-based study. CMAJ. 2012.
  24. Lescot T., Karvellas C., Beaussier M., Magder S. Acquired liver injury in the intensive care unit. Anesthesiology. 2012; 117: 898-904.
  25. Jalan R., Olde Damink S.W., Deutz N.E., Hayes P.C., Lee A. Moderate hypothermia in patients with acute liver failure and uncontrolled intracranial hypertension. Gastroenterology. 2004; 127 (5): 1338-46.
  26. Lee W.M., Hynan L.S., Rossaro L. et al. Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. Gastroenterology. 2009; 137: 856-64.
  27. Vaquero J., Polson J., Chung C. et al. Infection and the progression of hepatic encephalopathy in acute liver failure. Gastroenterology. 2003; 125: 755-64.
  28. Berry P.A., Antoniades C.G., Hussain M.J. et al. Admission levels and early changes in serum interleukin-10 are predictive of poor outcome in acute liver failure and decompensated cirrhosis. Liver Int. 2010; 30: 733-40.
  29. Agarwal B., Wright G., Gatt A. et al. Evaluation of coagulation abnormalities in acute liver failure. J Hepatol. 2012; 57: 780-6.
  30. Stravitz R.T., Lisman T., Luketic V.A. et al. Minimal effects of acute liver injury/acute liver failure on hemostasis as assessed by thromboelastography. J. Hepatol. 2012; 56: 129-36.
  31. Eefsen M., Dethloff T., Frederiksen H.-J., Hauerberg J., Hansen B.A., Larsen F.S. Comparison of terlipressin and noradrenalin on cerebral perfusion, intracranial pressure and cerebral extracellular concentrations of lactate and pyruvate in patients with acute liver failure in need of inotropic support. J. Hepatol. 2007; 47: 381-6.
  32. Etogo-Asse F.-E., Vincent R.P., Hughes S.A. et al. High density lipoprotein in patients with liver failure: relation to sepsis, adrenal function and outcome of illness. Liver Int. 2012; 32: 128-36.
  33. Vaquero J. Therapeutic hypothermia in the management of acute liver failure. Neurochem. Int. 2012; 60: 723-35.
  34. Desjardins P., Du T., Jiang W., Peng L., Butterworth R. Pathogenesis of hepatic encephalopathy and brain edema in acute liver failure: role of glutamine redefined. Neurochem. Int. 2012; 60: 690-6.
  35. Bernal W., Hall C., Karvellas C.J., Auzinger G., Sizer E., Wendon J. Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure. Hepatology. 2007; 46: 1844-52.
  36. Butterworth R.F. Hepatic encephalopathy: a central neuroinflammatory disorder? Hepatology. 2011; 53: 1372-6.
  37. Delcker A.M., Jalan R., Comes G. L-ornithine-l-aspartate vs. placebo in the treatment of hepatic encephalopathy: a meta-analysis of randomised placebo-controlled trials using individual data. Hepatology. 2000; 32: 310A.
  38. Acharya S.K., Bhatia V., Sreenivas V., Khanal S., Panda S.K. Efficacy of L-ornithine L-aspartate in acute liver failure: a double-blind, randomized, placebo-controlled study. Gastroenterology. 2009; 136: 2159-68.
  39. Murphy N., Auzinger G., Bernal W., Wendon J. The effect of hypertonic sodium chloride on intracranial pressure in patients with acute liver failure. Hepatology. 2004; 39: 464-70.
  40. Jalan R., Olde Damink S.W., Deutz N.E., Hayes P.C., Lee A. Moderate hypothermia in patients with acute liver failure and uncontrolled intracranial hypertension. Gastroenterology. 2004; 127: 1338-46.
  41. Larsen F.S., Murphy N., Bernal W. et al. Prophylactic effect of mild hypothermia to prevent brain edema in patients with acute liver failure: results of a multicenter, randomized, controlled trial. J Hepatol. 2011; 54 (Suppl.): S26-26.
  42. Vaquero J., Fontana R.J., Larson A.M. et al. Complications and use of intracranial pressure monitoring in patients with acute liver failure and severe encephalopathy. Liver Transpl. 2005; 11: 1581-9.
  43. Wendon J., Lee W. Encephalopathy and cerebral edema in the setting of acute liver failure: pathogenesis and management. Neurocrit. Care. 2008; 9: 97-102.
  44. Leithead J.A., Ferguson J.W., Bates C.M. et al. The systemic inflammatory response syndrome is predictive of renal dysfunction in patients with non-paracetamol-induced acute liver failure. Gut. 2009; 58: 443-4.
  45. O’Riordan A., Brummell Z., Sizer E. et al. Acute kidney injury in patients admitted to a liver intensive therapy unit with paracetamol-induced hepatotoxicity. Nephrol. Dial. Transplant. 2011; 26: 3501-8.
  46. Davenport A. Continuous renal replacement therapies in patients with liver disease. Semin. Dial. 2009; 22: 169-72.
  47. O’Grady J.G., Alexander G.J., Hayllar K.M., Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology. 1989; 97 (2): 439-45.
  48. Schiødt F.V., Rossaro L., Stravitz R.T., Shakil A.O., Chung R.T., Lee W.M. Gc-globulin and prognosis in acute liver failure. Liver Transpl. 2005; 11 (10): 1223-7.
  49. Simpson K.J., Bates C.M., Henderson N.C. et al. The utilization of liver transplantation in the management of acute liver failure: comparison between acetaminophen and non-acetaminophen etiologies. Liver Transpl. 2009; 15: 600-9.
  50. O’Grady J.G., Alexander G.J., Hayllar K.M., Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology. 1989; 97: 439-45.
  51. McPhail M.J.W., Wendon J.A., Bernal W. Meta-analysis of performance of Kings’ College Hospital Criteria in prediction of outcome in non-paracetamol-induced acute liver failure. J. Hepatol. 2010; 53: 492-9.
  52. Germani G., Theocharidou E., Adam R. et al. Liver transplantation for acute liver failure in Europe: outcomes over 20 years from the ELTR database. J. Hepatol. 2012; 57: 288-96.
  53. Bernal W., Cross T.J.S., Auzinger G. et al. Outcome after wait-listing for emergency liver transplantation in acute liver failure: a single centre experience. J. Hepatol. 2009; 50: 306-13.
  54. Hughes R.D., Mitry R.R., Dhawan A. Current status of hepatocyte transplantation. Transplantation. 2012; 93: 342-7.
  55. Stutchfield B.M., Simpson K., Wigmore S.J. Systematic review and meta-analysis of survival following extracorporeal liver support. Br. J. Surg. 2011; 98: 623-31.
  56. Tritto G., Davies N.A., Jalan R. Liver replacement therapy. Semin. Respir. Crit. Care Med. 2012; 33: 70-9.
  57. Saliba F., Camus C., Durand F. et al. Albumin dialysis with a noncell artificial liver support device in patients with acute liver failure: a randomized, controlled trial. Ann. Intern. Med. 2013; 159: 522-31.
  58. Demetriou A.A., Brown R.S. Jr., Busuttil R.W. et al. Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann. Surg. 2004; 239: 660-7.
  59. Larsen F.S., Schmidt L.E., Wendon J. et al. Liver assisting with high-volume plasma exchange in patients with acute liver failure. Hepatology. 2010; 52: 376A-376A.

版权所有 © Eco-vector, 2017


 


##common.cookie##